The major objective of the Proteomics and Biostatistics Core (PBC) is to perform quantitative analysis of changes in the protein expression for project #1 and project #3 using two dimensional differential in gel electrophoresis (2-D DICE) coupled with mass spectrometry and/or shotgun label-free approaches as well as genotype detections, polymorphism analyses (SNPs and CNPs), time-to-event and disease association studies in project #4. Furthermore, the core will facilitate the interpretation of high throughput data with sophisticated statistical, functional, and Pathway analysis tools. Finally, the core will develop and apply an integrated modeling method to test the fundamental hypothesis of the grant. Specifically, in Aim 1 we will utilize a suite of appropriate proteomics technologies to study changes in protein expression in cells.
This Aim will also include validation of expression changes using Western and MSWestern technologies.
In Aim 2, we will use statistical, and computational methods to facilitate the interpretation of high throughput data from 2-D DICE and label-free experiments of projects #1 and #3 as well as the genotyping data from SNP arrays in project #4. Furthermore, we will conduct pathway analysis using Ingenuity Pathway software to define the networks and their controlling transcription factors and signaling molecules that are turned on and off based on the proteomics and genomics data.
In Aim 3, we will test the fundamental hypothesis of the PPG through a statistical analysis of the outcomes and predictors from the individual projects, based upon common sample usage and/or patient participation.

National Institute of Health (NIH)
National Institute of Dental & Craniofacial Research (NIDCR)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZDE1-JH)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Case Western Reserve University
United States
Zip Code
Feng, Zhimin; Jia, Xun; Adams, Mark D et al. (2014) Epithelial innate immune response to Acinetobacter baumannii challenge. Infect Immun 82:4458-65
Chung, Charlotte Y; Alden, Stephanie L; Funderburg, Nicholas T et al. (2014) Progressive proximal-to-distal reduction in expression of the tight junction complex in colonic epithelium of virally-suppressed HIV+ individuals. PLoS Pathog 10:e1004198
Willie, B; Hall, N B; Stein, C M et al. (2014) Association of Toll-like receptor polymorphisms with HIV status in North Americans. Genes Immun 15:569-77
Cheruvu, Vinay K; Igo Jr, Robert P; Jurevic, Richard J et al. (2014) African ancestry influences CCR5 -2459G>A genotype-associated virologic success of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 66:102-7
Ghosh, Santosh K; McCormick, Thomas S; Eapen, Betty L et al. (2013) Comparison of epigenetic profiles of human oral epithelial cells from HIV-positive (on HAART) and HIV-negative subjects. Epigenetics 8:703-9
Feng, Zhimin; Dubyak, George R; Jia, Xun et al. (2013) Human ?-defensin-3 structure motifs that are important in CXCR4 antagonism. FEBS J 280:3365-75
Golden, Jackelyn B; McCormick, Thomas S; Ward, Nicole L (2013) IL-17 in psoriasis: implications for therapy and cardiovascular co-morbidities. Cytokine 62:195-201
Meisch, Jeffrey P; Nishimura, Michiko; Vogel, Ryan M et al. (2013) Human ýý-defensin 3 peptide is increased and redistributed in Crohn's ileitis. Inflamm Bowel Dis 19:942-53
Tebit, Denis M; Ndembi, Nicaise; Weinberg, Aaron et al. (2012) Mucosal transmission of human immunodeficiency virus. Curr HIV Res 10:3-8
Funderburg, Nicholas T; Jadlowsky, Julie K; Lederman, Michael M et al. (2011) The Toll-like receptor 1/2 agonists Pam(3) CSK(4) and human ?-defensin-3 differentially induce interleukin-10 and nuclear factor-?B signalling patterns in human monocytes. Immunology 134:151-60

Showing the most recent 10 out of 16 publications